Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin After Large Myocardial Infarction (REVEAL) trial

BACKGROUND: Acute myocardial infarction (MI) remains a leading cause of death despite advances in pharmacologic and percutaneous therapies. Animal models of ischemia/reperfusion have demonstrated that single-dose erythropoietin (EPO) may reduce infarct size, decrease apoptosis, and increase neovascu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Melloni, Chiara, Rao, Sunil V., Povsic, Thomas J., Melton, Laura, Kim, Raymond J., Kilaru, Rakhi, Patel, Manesh, Talan, Mark, Ferrucci, Luigi, Longo, Dan L., Lakatta, Edward G., Najjar, Samer S., Harrington, Robert A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018783/
https://ncbi.nlm.nih.gov/pubmed/21095264
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ahj.2010.09.007
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados